PRMT5 and lymphoma: To validate canine lymphoma as a useful comparison to human lymphoma while validating PRMT5 as a rational therapeutic target in canine lymphoma, we evaluated the prevalence of PRMT5 expression and correlation with histological subtype in canine lymphomas.